New study tracks safety of popular Crohn's and colitis drugs over time
NCT ID NCT04372108
First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 3 times
Summary
This study looks at the long-term safety of the drug ustekinumab compared to other biologic treatments in adults with Crohn's disease or ulcerative colitis. Researchers will use health records from the Department of Defense to track rates of cancer, serious infections, and other risks. About 1,056 participants who are new users of these drugs will be followed to see how safe they are over time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLITIS, ULCERATIVE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
BAMC
RECRUITINGHouston, Texas, 78234, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.